We are live on
!
Find out more
Capital Analysts LLC Portfolio holdings
AUM
$4.34B
Turnover
9.37%
1-Year Est. Return
17.55%
This Fund
S&P 500
This Quarter
Est. Return
+2.85%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+179.02%
AUM
$701M
AUM Growth
+$66.8M
(+11%)
Cap. Flow
+$49.7M
Cap. Flow
% of AUM
7.1%
Top 10 Holdings %
Top 10 Hldgs %
47.13%
Holding
388
New
53
Increased
160
Reduced
59
Closed
14
Avg Time Held
2
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.1M |
| 2 |
Becton Dickinson
BDX
|
+$3.12M |
| 3 |
Oracle
ORCL
|
+$2.96M |
| 4 |
Travelers Companies
TRV
|
+$2.96M |
| 5 |
Abbott
ABT
|
+$2.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Properties
BXP
|
+$2.49M |
| 2 |
CVS Health
CVS
|
+$2.42M |
| 3 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$969K |
| 4 |
General Mills
GIS
|
+$938K |
| 5 |
Simon Property Group
SPG
|
+$842K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 69.05% |
| 2 | Technology | 5% |
| 3 | Financials | 4.98% |
| 4 | Healthcare | 4.2% |
| 5 | Industrials | 4.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
iShares Biotechnology ETF
IBB
$10.4B
| $264K | 0.04% |
2,550
| – | – |
2017 Q1
1 quarter
|
|
177
Gilead Sciences
GILD
$194B
| $263K | 0.04% |
3,720
-2,775
| -43% | -$185K |
2013 Q2
16 quarters
|
|
178
Columbia Emerging Markets Consumer ETF
ECON
$295M
| $263K | 0.04% |
10,080
| – | – |
2015 Q3
7 quarters
|
|
179
NewMarket
NEU
$8.01B
| $262K | 0.04% |
569
| – | – |
2013 Q2
16 quarters
|
|
180
Watsco Inc
WSO
$12.2B
| $254K | 0.04% |
1,646
+1
| +0.1% | +$143 |
2013 Q2
16 quarters
|
|
181
Chipotle Mexican Grill
CMG
$38B
| $253K | 0.04% |
30,400
+9,050
| +42% | +$84K |
2016 Q3
3 quarters
|
|
182
National Beverage
FIZZ
$3.28B
| $252K | 0.04% |
5,386
| – | – |
2016 Q3
3 quarters
|
|
183
Direxion Daily Healthcare Bull 3X ETF
CURE
$185M
| $250K | 0.04% |
6,000
| – | – |
2016 Q3
3 quarters
|
|
184
DELISTED
Unilever NV New York Registry Shares
UN
| $249K | 0.04% |
4,511
| – | – |
2013 Q4
14 quarters
|
|
185
iShares MSCI EAFE ETF
EFA
$76.9B
| $237K | 0.03% |
3,632
+1,293
| +55% | +$83.7K |
2013 Q2
16 quarters
|
|
|
RDS.B
186
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $222K | 0.03% |
4,080
| – | – |
2016 Q4
2 quarters
|
|
187
Vanguard Morningstar Mid-Cap ETF
VO
$106B
| $221K | 0.03% |
6,216
-1,160
| -16% | -$41K |
2015 Q2
8 quarters
|
|
188
First Citizens BancShares
FCNCA
$24B
| $218K | 0.03% |
585
| – | – |
2017 Q1
1 quarter
|
|
189
Manhattan Associates
MANH
$13B
| $215K | 0.03% |
4,465
| – | – |
2016 Q2
4 quarters
|
|
190
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.1B
| $213K | 0.03% |
1,000
-200
| -17% | -$42K |
2016 Q4
2 quarters
|
|
191
State Street SPDR S&P Regional Banking ETF
KRE
$3.31B
| $209K | 0.03% |
3,800
-200
| -5% | -$10.8K |
2016 Q4
2 quarters
|
|
192
Hingham Institution for Saving
HIFS
$645M
| $203K | 0.03% |
+1,115
| New | +$197K |
2017 Q2
0 quarters
|
|
193
Carnival Corporation Ltd
CCL
$35.5B
| $201K | 0.03% |
3,070
| – | – |
2013 Q2
16 quarters
|
|
194
Vanguard Morningstar Small-Cap Growth ETF
VBK
$22.2B
| $200K | 0.03% |
1,375
-256
| -16% | -$36.7K |
2015 Q2
8 quarters
|
|
195
Balchem Corp
BCPC
$5.43B
| $197K | 0.03% |
+2,540
| New | +$202K |
2017 Q2
0 quarters
|
|
196
Acuity Brands
AYI
$9.04B
| $197K | 0.03% |
970
+290
| +43% | +$51.2K |
2016 Q4
2 quarters
|
|
197
iShare MSCI Eurozone ETF
EZU
$9.25B
| $196K | 0.03% |
4,850
+3,350
| +223% | +$134K |
2016 Q3
3 quarters
|
|
198
First Trust Exchange-Traded Fund VI Multi-Asset Diversified Income Index Fund
MDIV
$413M
| $193K | 0.03% |
10,006
-485
| -5% | -$9.42K |
2015 Q2
8 quarters
|
|
199
WisdomTree India Earnings Fund ETF
EPI
$1.83B
| $190K | 0.03% |
7,765
| – | – |
2013 Q4
14 quarters
|
|
200
Halliburton
HAL
$28B
| $189K | 0.03% |
4,431
| – | – |
2013 Q2
16 quarters
|
|
Similar funds
ZP
AIIMS
Capital Analysts LLC's Q2 2017 Portfolio in Review
As of Q2 2017, Capital Analysts LLC held 388 positions worth $701M, up 11% from $634M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Capital Analysts LLC deployed $49.7M of net new capital in Q2 2017, opening 53 new positions and adding to 160 existing holdings. Its largest new stake was Apple: 110,832 shares worth $3.99M.
By sector, the portfolio is most concentrated in Miscellaneous at 69% of assets, down from 72% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Boston Properties, an estimated $2.49M trimmed.
- Capital Analysts LLC's largest Q2 2017 buy was Apple: 110,832 shares worth $3.99M.
- Capital Analysts LLC added most to Oracle in Q2 2017, an estimated $2.96M increase.
- Capital Analysts LLC's biggest Q2 2017 reduction was Boston Properties, cutting an estimated $2.49M.
- Capital Analysts LLC fully exited General Mills in Q2 2017, selling an estimated $938K.
- Capital Analysts LLC's ten largest holdings make up 47% of its $701M portfolio in Q2 2017.
- Capital Analysts LLC opened 53 new positions and closed 14 in Q2 2017.
- Capital Analysts LLC's portfolio value rose 11% quarter-over-quarter to $701M.
Based on Capital Analysts LLC's 13F filing for Q2 2017, filed 8 Aug 2017.